Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olof Selroos

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2024
Structural and hydrodynamic controls on fluid travel time distributions across fracture networksPhilippe Davy, Romain Le Goc, Caroline Darcel, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
<i>ACE</i> gene variants and sarcoidosis in a Finnish populationElisa Lahtela, Annika Wennerström, Anne Pietinalho, et al.
Pediatric Research|May 21, 2010
Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma studyMarkku Turpeinen, Anna S Pelkonen, Kurt Nikander, et al.
The Science of the Total Environment|August 14, 2021
Hydrological control of water quality - Modelling base cation weathering and dynamics across heterogeneous boreal catchmentsElin Jutebring Sterte, Fredrik Lidman, Nicola Balbarini, et al.
Current Medical Research and Opinion|May 20, 2006
Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness studyMikael Lundborg, Sören Wille, Leif Bjermer, et al.
Therapeutic Advances in Respiratory Disease|May 19, 2011
Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?Michel Aubier, John Haughney, Olof Selroos, et al.
Respiratory Medicine|November 29, 2011
Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label studyOnno C P van Schayck, John Haughney, Michel Aubier, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2016
The Finnish experience to save asthma costs by improving care in 1987-2013Tari Haahtela, Fredrik Herse, Jussi Karjalainen, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthmaTari Haahtela, Klaus Tamminen, Tuomo Kava, et al.
Pediatric Research|October 28, 2009
Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma. The Helsinki early intervention childhood asthma studyMarkku Turpeinen, Hanna Raitio, Anna S Pelkonen, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2024
Structural and hydrodynamic controls on fluid travel time distributions across fracture networksPhilippe Davy, Romain Le Goc, Caroline Darcel, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
<i>ACE</i> gene variants and sarcoidosis in a Finnish populationElisa Lahtela, Annika Wennerström, Anne Pietinalho, et al.
Pediatric Research|May 21, 2010
Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma studyMarkku Turpeinen, Anna S Pelkonen, Kurt Nikander, et al.
The Science of the Total Environment|August 14, 2021
Hydrological control of water quality - Modelling base cation weathering and dynamics across heterogeneous boreal catchmentsElin Jutebring Sterte, Fredrik Lidman, Nicola Balbarini, et al.
Current Medical Research and Opinion|May 20, 2006
Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness studyMikael Lundborg, Sören Wille, Leif Bjermer, et al.
Therapeutic Advances in Respiratory Disease|May 19, 2011
Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?Michel Aubier, John Haughney, Olof Selroos, et al.
Respiratory Medicine|November 29, 2011
Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label studyOnno C P van Schayck, John Haughney, Michel Aubier, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2016
The Finnish experience to save asthma costs by improving care in 1987-2013Tari Haahtela, Fredrik Herse, Jussi Karjalainen, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthmaTari Haahtela, Klaus Tamminen, Tuomo Kava, et al.
Pediatric Research|October 28, 2009
Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma. The Helsinki early intervention childhood asthma studyMarkku Turpeinen, Hanna Raitio, Anna S Pelkonen, et al.
Pageof 4